RxDoctor Payments DataLook up a doctor →

John Baber, MD

Gastroenterology · Little Rock, ARNPI 1699762484

Payments from drug & device makers

$1,780,631in general payments, 2019–2025

Across 970 payments — averaging $1835.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vanda Pharmaceuticals Inc.$598K
  • AbbVie$481K
  • Ironwood Pharmaceuticals, Inc$422K
  • Braintree Laboratories, Inc.$188K
  • Phathom Pharmaceuticals, Inc.$47K
  • Adare Pharmaceuticals, Inc.$21K
  • plus $23K from 46 others
$300in research payments, 2019–2025

Across 1 payment — averaging $300.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Braintree Laboratories, Inc.$300

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Vanda Pharmaceuticals Inc.113$598,050
AbbVie(2 entities)427$481,356
Ironwood Pharmaceuticals, Inc48$421,950
Braintree Laboratories, Inc.74$188,256
Phathom Pharmaceuticals, Inc.18$46,789
Adare Pharmaceuticals, Inc.3$20,861
Eli Lilly1$18,361
Johnson & Johnson(2 entities)46$944
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC39$602
Pfizer33$439
Takeda Pharmaceuticals U.S.A., Inc.16$306
Ferring Pharmaceuticals Inc.22$295
Bristol Myers Squibb15$187
Intercept Pharmaceuticals, Inc.11$169
Regeneron Healthcare Solutions, Inc.5$166
Nestle Healthcare Nutrition Inc.7$144
W. L. Gore & Associates, Inc.1$128
UCB, Inc.8$117
Evoke Pharma, Inc.6$102
Actelion Pharmaceuticals US, Inc.6$100
Gilead6$96
Aimmune Therapeutics, Inc.5$92
Jazz Pharmaceuticals Inc.5$90
Lilly USA, LLC5$83
Redhill Biopharma Inc.5$81
Ipsen Biopharmaceuticals, Inc4$80
Mallinckrodt Enterprises LLC4$75
Organogenesis Inc.3$70
GSK1$63
Mauna Kea Technologies, Inc.2$52
Sanofi2$46
Merck3$42
United Therapeutics Corporation2$40
Enterra Medical, Inc.2$40
Boehringer Ingelheim3$40
Boston Scientific2$38
Dova Pharmaceuticals2$27
Endogastric Solutions, Inc1$23
Grifols USA, LLC1$22
Itamar Medical Inc1$20
Medtronic1$20
Capsovision, Inc.1$20
Madrigal Pharmaceuticals1$20
Micro-tech Endoscopy USA, Inc.1$18
AstraZeneca1$17
Ardelyx, Inc.1$16
Advanced Respiratory, Inc1$15
Novo Nordisk1$15
Vivus LLC1$15
Teva Pharmaceuticals USA, Inc.1$14
Paratek Pharmaceuticals, Inc.1$13
Organon1$7

How this compares

$1,780,631 in reported general payments places this provider in the 95th percentile of 108 gastroenterology providers in Arkansas.

See all gastroenterology providers in Arkansas →

Medicare billing

Part B allowed, 2024
$136,778
Medicare patients
498
Services billed
1,148

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Little Rock

See the full list for Arkansas →

Where these figures come from

Is this you, or does something look wrong? →